BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18858635)

  • 1. Neostigmine toxicity; report of fatality following diagnostic test for myasthenia gravis.
    MERRILL GG
    J Am Med Assoc; 1948 May; 137(4):362. PubMed ID: 18858635
    [No Abstract]   [Full Text] [Related]  

  • 2. The intra-arterial injection of neostigmine as a diagnostic test in myasthenia gravis.
    HUTCHINSON EC; MATTHEWS WB
    J Neurol Neurosurg Psychiatry; 1953 Feb; 16(1):47-8. PubMed ID: 13023440
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of myasthenia gravis: Comparison of anti-nicotinic acetyl choline receptor antibodies, repetitive nerve stimulation and Neostigmine tests at a tertiary neuro care centre in India, a ten year study.
    Patil SA; Bokoliya SC; Nagappa M; Taly AB
    J Neuroimmunol; 2016 Mar; 292():81-4. PubMed ID: 26943963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems in the diagnosis of myasthenia gravis; a 20-year report of the neostigmine test.
    VIETS HR; SCHWAB RS
    Trans Am Neurol Assoc; 1955-1956; (80th Meeting):36-41. PubMed ID: 13311994
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous neostigmine in diagnosis of myasthenia gravis.
    TETHER JE
    Ann Intern Med; 1948 Dec; 29(6):1132-8. PubMed ID: 18100411
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis: report of case receiving unusual dosage of neostigmine.
    RIDER JA; PICKETT WH; HARRISON AW
    Ann Intern Med; 1951 Aug; 35(2):463-8. PubMed ID: 14857617
    [No Abstract]   [Full Text] [Related]  

  • 7. Stapedius reflexometry. A diagnostic test of myasthenia gravis.
    Ahuja GK; Verma A; Ghosh P; Nagaraj MN
    J Neurol Sci; 1980 Jun; 46(3):311-4. PubMed ID: 7381518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the metabolism of neostigmine in patients with myasthenia gravis.
    SCOTT CA; NOWELL PT; WILSON A
    J Pharm Pharmacol; 1962 Dec; 14(Suppl)():31T-33T. PubMed ID: 13992512
    [No Abstract]   [Full Text] [Related]  

  • 9. Myasthenia gravis: report of a case with exophthalmos, without hyperthyroidism, relieved by neostigmine.
    HATCH HA
    N Engl J Med; 1952 May; 246(22):856-8. PubMed ID: 14929332
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-varicella myasthenia gravis.
    Saha A; Batra P; Vilhekar KY; Chaturvedi P
    Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis.
    KEELING CW
    J Oral Surg (Chic); 1951 Jul; 9(3):224-32. PubMed ID: 14851134
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of myasthenia gravis.
    SCHWAB RS
    N Engl J Med; 1963 Mar; 268():596-7 contd. PubMed ID: 13987334
    [No Abstract]   [Full Text] [Related]  

  • 13. MYASTHENIA GRAVIS IN A MUSOGA GIRL. CASE REPORT.
    SINGH JS
    East Afr Med J; 1964 Nov; 41():535-6. PubMed ID: 14249963
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostigmine-responsiveness and the diagnosis of myasthenia gravis.
    ROWLAND LP
    Neurology; 1955 Sep; 5(9):612-23. PubMed ID: 13253829
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of neostigmine and pyridostigmine in the urine of patients with myasthenia gravis.
    NOWELL PT; SCOTT CA; WILSON A
    Br J Pharmacol Chemother; 1962 Jun; 18(3):617-24. PubMed ID: 14480648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis in a case of malignant thymoma resistant to neostigmine therapy.
    RIDER JA; McDONALD R
    Am J Med Sci; 1950 Jan; 219(1):71-5, illust. PubMed ID: 15402307
    [No Abstract]   [Full Text] [Related]  

  • 17. Report of a case of myasthenia gravis.
    BRYAN FA
    J Indiana State Med Assoc; 1956 Mar; 49(3):257-8. PubMed ID: 13306994
    [No Abstract]   [Full Text] [Related]  

  • 18. [DRUG THERAPY OF MYASTHENIA GRAVIS].
    SKINHOJ E
    Nord Med; 1964 Feb; 71():277-9. PubMed ID: 14118993
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of myasthenia gravis; clinical experiences with the treatment of myasthenia gravis pseudoparalytica with pyridostigmine].
    SEIBERT P
    Dtsch Med Wochenschr; 1953 May; 78(22):805-7. PubMed ID: 13067995
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of myasthenia gravis; prolonged action with multiple-dose tablets of neostigmine bromide and mestinon bromide.
    SCHWAB RS; OSSERMAN KE; TETHER JE
    J Am Med Assoc; 1957 Oct; 165(6):671-4. PubMed ID: 13462827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.